Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / India

Lupin Acquires Majority Stake In Pharma Dynamics

September 2008 | Company News Alert

India's Lupin has expanded its footprint in South Africa through the acquisition of a majority 60% stake in local firm Pharma Dynamics. The stake in Pharma Dynamics should allow Lupin more direct access to South Africa's pharmaceutical market, which was estimated to be worth

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Aspen And Matrix Reorganise Partnerships

Companies / India South Africa's Aspen Pharmacare and India's Matrix Laboratories have divested their 50-50 active pharmaceutical ingredient (API) manufacturing joint ventures. Aspen will acquire 50% of South Africa-based...
October 2008
Zydus Cadila To Take Stake In Simayla

Companies / India Indian generics firm Zydus Cadila has announced that it is to acquire 70% of South Africa's Simayla Pharmaceuticals, as part of its drive to penetrate southern Africa's generics markets.
June 2008
India's IBPL To Launch Oncology Biotech Products

Companies / India Demonstrating faith in the Gulf states' appetite for novel drugs, India's Intas Biopharmaceuticals (IBPL) is to register itself in the Gulf Co-operation Council (GCC) region. IBPL is initially planning...
February 2008
Trade With India Set To Boom

Companies / India South Africa-India bilateral trade is set for strong growth according to the Federation of Indian Chambers of Commerce and Industry (FICCI). Overall trade is expected to reach US$12bn by 2010 - triple...
October 2007
Ranbaxy Expands South African Footprint

Companies / India Indian drugmaker Ranbaxy has expanded its presence in the South African pharmaceuticals market after completing the purchase of local producer Be-Tabs Pharmaceuticals in a deal worth ZAR500mn (US$72.17mn)....
May 2007
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS